Fresenius News More News
Historical Prices for Fresenius
Date | Open | Close | Daily High | Daily Low |
---|
Price change over selected period:
0%
0
Fresenius Analyst Opinions
- All
- Buy
- Hold
- Sell
Date | Analyst | Rating | Price |
---|
Fresenius Estimates* in EUR
2024 | 2025 | 2026 | 2027 | 2028 | |
---|---|---|---|---|---|
Revenue | 21,607 | 22,719 | 23,801 | 24,956 | 26,191 |
Dividend | 0.85 | 1.03 | 1.21 | 0.86 | 0.96 |
Dividend Yield (in %) | 2.53 % | 3.10 % | 3.63 % | 2.59 % | 2.88 % |
EPS | 2.91 | 3.38 | 3.83 | 4.17 | 4.57 |
P/E Ratio | 11.49 | 9.89 | 8.73 | 8.00 | 7.31 |
EBIT | 2,348 | 2,684 | 2,939 | 3,150 | 3,356 |
EBITDA | 3,517 | 3,892 | 4,148 | 4,457 | 4,767 |
Net Profit | 1,194 | 1,821 | 2,059 | 2,312 | 2,515 |
Net Profit Adjusted | 1,606 | 1,900 | 2,167 | 2,352 | 2,575 |
Pre-Tax Profit | 1,766 | 2,270 | 2,576 | 2,810 | 3,069 |
Pre-Tax Profit Reported | 1,633 | 2,175 | 2,512 | 2,752 | 3,060 |
EPS (Non-GAAP) ex. SOE | - | - | - | - | - |
EPS (GAAP) | 1.80 | 3.19 | 3.62 | 4.08 | 4.46 |
Gross Income | 5,195 | 5,790 | 6,163 | 6,645 | 6,974 |
Cash Flow from Investing | -941 | -1,289 | -1,350 | -1,198 | -1,254 |
Cash Flow from Operations | 2,619 | 2,703 | 2,927 | 3,172 | 3,456 |
Cash Flow from Financing | -446 | -521 | -487 | -843 | -897 |
Cash Flow per Share | 4.34 | 4.63 | 4.88 | 5.63 | 6.14 |
Free Cash Flow | 1,587 | 1,663 | 1,834 | - | - |
Free Cash Flow per Share | 2.78 | 2.35 | 2.63 | - | - |
Book Value per Share | 34.39 | 36.52 | 39.17 | 46.19 | 49.99 |
Net Debt | 12,346 | 11,672 | 10,798 | 7,795 | 6,283 |
Research & Development Exp. | 650 | 675 | 703 | 679 | 710 |
Capital Expenditure | 1,127 | 1,183 | 1,242 | 1,198 | 1,254 |
Selling, General & Admin. Exp. | 3,083 | 3,007 | 3,114 | 2,870 | 2,958 |
Shareholder’s Equity | 19,676 | 20,701 | 22,238 | 26,015 | 28,156 |
Total Assets | 45,978 | 47,209 | 48,633 | 51,428 | 53,548 |
Previous Quarter ending 09/30/24 |
Current Quarter ending 12/31/24 |
Next Quarter ending 03/31/25 |
Current Year ending 12/31/24 |
Next Year ending 12/31/25 |
|
---|---|---|---|---|---|
Earnings Estimates | |||||
No. of Analysts | 6 | 6 | 1 | 13 | 13 |
Average Estimate | 0.661 EUR | 0.682 EUR | 0.875 EUR | 2.906 EUR | 3.376 EUR |
Year Ago | -0.728 EUR | -1.090 EUR | 0.494 EUR | -1.055 EUR | - |
Publish Date | 11/6/2024 | 3/26/2025 | 5/1/2025 | - | - |
Revenue Estimates | |||||
No. of Analysts | 6 | 6 | 1 | 13 | 13 |
Average Estimate | 5,240 EUR | 5,407 EUR | 5,450 EUR | 21,607 EUR | 22,719 EUR |
Year Ago | 5,518 EUR | 5,678 EUR | 5,704 EUR | 22,299 EUR | - |
Publish Date | 11/6/2024 | 3/26/2025 | 5/1/2025 | - | - |
* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet
Income Statements in Mio. EUR
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales | 22,299.00 | 40,637.00 | 37,077.00 | 36,277.00 | 35,409.00 | 33,530.00 | 33,886.00 |
Change of sales in % | -45.13 | 9.60 | 2.21 | 2.45 | 5.60 | -1.05 | 14.98 |
Gross profit on sales | 5,058.00 | 10,522.00 | 9,809.00 | 10,316.00 | 10,348.00 | 9,818.00 | 10,461.00 |
Gross profit on sales change in % | -51.93 | 7.27 | -4.91 | -0.31 | 5.40 | -6.15 | 10.15 |
Operating income | 1,296.00 | 2,969.00 | 3,600.00 | 4,144.00 | 4,321.00 | 4,215.00 | 4,379.00 |
Operating income change in % | -56.35 | -17.53 | -13.13 | -4.10 | 2.51 | -3.75 | 2.58 |
Income before tax | 727.00 | 2,746.00 | 3,559.00 | 3,726.00 | 3,912.00 | 4,664.00 | 3,938.00 |
Income before tax change in % | -73.53 | -22.84 | -4.48 | -4.75 | -16.12 | 18.44 | 5.86 |
Income after tax | 353.00 | 1,372.00 | 1,818.00 | 1,707.00 | 1,883.00 | 2,027.00 | 1,814.00 |
Income after tax change in % | -74.27 | -24.53 | 6.50 | -9.35 | -7.10 | 11.74 | 16.28 |
Balance Sheet in Mio. EUR
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Total liabilities | 25,633.00 | 44,197.00 | 42,674.00 | 40,623.00 | 40,426.00 | 31,695.00 | 31,413.00 |
Long-term liabilities per share | 28.95 | 54.77 | 49.95 | 49.66 | 48.39 | 33.14 | 37.45 |
Equity | 19,651.00 | 32,218.00 | 29,288.00 | 26,023.00 | 26,580.00 | 25,008.00 | 21,720.00 |
Equity change in % | -6.94 | 7.46 | 12.09 | 1.02 | 8.87 | 12.81 | 7.87 |
Balance sheet total | 45,284.00 | 76,415.00 | 71,962.00 | 66,646.00 | 67,006.00 | 56,703.00 | 53,133.00 |
Balance sheet total change in % | -40.74 | 6.19 | 7.98 | -0.54 | 18.17 | 6.72 | 13.78 |
Key Data in EUR
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|---|
Sales per share | 39.59 | 72.40 | 66.43 | 65.04 | 63.52 | 60.16 | 60.78 |
P/E ratio (year end quote, basic EPS) | - | 10.74 | 10.87 | 12.36 | 14.84 | 11.62 | 19.90 |
P/E ratio (year end quote, diluted EPS) | - | 10.74 | 10.87 | 12.36 | 14.85 | 11.66 | 20.02 |
P/E ratio (year end quote) | - | 10.74 | 10.87 | 12.36 | 14.84 | 11.62 | 19.90 |
Dividend yield in % | 0.00 | 3.50 | 2.60 | 2.33 | 1.67 | 1.89 | 1.15 |
Equity ratio in % | 43.40 | 42.16 | 40.70 | 39.05 | 39.67 | 44.10 | 40.88 |
Debt ratio in % | 56.60 | 57.84 | 59.30 | 60.95 | 60.33 | 55.90 | 59.12 |
Fresenius Dividend Calendar
Date | Name | Dividend | *yield | Currency |
---|---|---|---|---|
2023 | Fresenius SE & Co. KGaA (St.) | 0.00 | 0.00 | EUR |
2022 | Fresenius SE & Co. KGaA (St.) | 0.92 | 3.50 | EUR |
2021 | Fresenius SE & Co. KGaA (St.) | 0.92 | 2.60 | EUR |
2020 | Fresenius SE & Co. KGaA (St.) | 0.88 | 2.33 | EUR |
2019 | Fresenius SE & Co. KGaA (St.) | 0.84 | 1.67 | EUR |
2018 | Fresenius SE & Co. KGaA (St.) | 0.80 | 1.89 | EUR |
2017 | Fresenius SE & Co. KGaA (St.) | 0.75 | 1.15 | EUR |
2016 | Fresenius SE & Co. KGaA (St.) | 0.62 | 0.83 | EUR |
2015 | Fresenius SE & Co. KGaA (St.) | 0.55 | 0.83 | EUR |
2014 | Fresenius SE & Co. KGaA (St.) | 0.44 | 1.02 | EUR |
2013 | Fresenius SE & Co. KGaA (St.) | 0.42 | 1.12 | EUR |
2012 | Fresenius SE & Co. KGaA (St.) | 0.37 | 1.26 | EUR |
2011 | Fresenius SE & Co. KGaA (St.) | 0.32 | 1.33 | EUR |
2010 | Fresenius SE & Co. KGaA (St.) | 0.29 | 1.37 | EUR |
2009 | Fresenius SE & Co. KGaA (St.) | 0.25 | 1.73 | EUR |
2008 | Fresenius SE & Co. KGaA (St.) | 0.23 | 1.93 | EUR |
2007 | Fresenius SE & Co. KGaA (St.) | 0.22 | 1.18 | EUR |
2006 | Fresenius SE & Co. KGaA (St.) | 0.19 | 1.13 | EUR |
2005 | Fresenius SE & Co. KGaA (St.) | 0.16 | 1.38 | EUR |
2004 | Fresenius SE & Co. KGaA (St.) | 0.15 | 1.81 | EUR |
2003 | Fresenius SE & Co. KGaA (St.) | 0.14 | 1.91 | EUR |
2002 | Fresenius SE & Co. KGaA (St.) | 0.13 | 3.17 | EUR |
2001 | Fresenius SE & Co. KGaA (St.) | 0.11 | 1.26 | EUR |
2000 | Fresenius SE & Co. KGaA (St.) | 0.10 | 0.85 | EUR |
*Yield of the Respective Date
Fresenius Calendar
Event | Estimate | Info | Date |
---|---|---|---|
Earnings Report | 0.682 EUR | Q4 2024 Earnings Release | 03/26/2025 |
Earnings Report | 0.875 EUR | Q1 2025 Earnings Release | 05/01/2025 |
Earnings Report | 0.937 EUR | Q2 2025 Earnings Release | 08/06/2025 |
Earnings Report | - | Q3 2025 Earnings Release | 11/04/2025 |
Earnings Report | - | Q4 2025 Earnings Release | 02/25/2026 |
Earnings Report | - | Q2 2026 Earnings Release | 08/05/2026 |
Fresenius Past Events
Event | Actual EPS | Info | Date |
---|---|---|---|
Earnings Report | 0.580 EUR | Q3 2024 Earnings Release | 11/06/2024 |
Earnings Report | -0.660 EUR | Q2 2024 Earnings Release | 07/31/2024 |
Annual General Meeting | - | Annual General Meeting | 05/17/2024 |
Earnings Report | 0.490 EUR | Q1 2024 Earnings Release | 05/08/2024 |
Earnings Report | -1.090 EUR | Q4 2023 Earnings Release | 02/21/2024 |
Earnings Report | -0.720 EUR | Q3 2023 Earnings Release | 11/02/2023 |
Earnings Report | 0.150 EUR | Q2 2023 Earnings Release | 08/02/2023 |
Annual General Meeting | - | Annual General Meeting | 05/17/2023 |
Earnings Report | 0.610 EUR | Q1 2023 Earnings Release | 05/09/2023 |
Earnings Report | 0.450 EUR | Q4 2022 Earnings Release | 02/22/2023 |
Earnings Report | 0.570 EUR | Q3 2022 Earnings Release | 10/30/2022 |
Earnings Report | 0.680 EUR | Q2 2022 Earnings Release | 07/27/2022 |
Annual General Meeting | - | Annual General Meeting | 05/13/2022 |
Earnings Report | 0.740 EUR | Q1 2022 Earnings Release | 05/04/2022 |
Earnings Report | 0.900 EUR | Q4 2021 Earnings Release | 02/22/2022 |
Fresenius Profile
Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.
Moody’s Daily Credit Risk Score
Fresenius Shareholder
Owner | in % |
---|---|
Freefloat | 72.99 |
Else Kröner-Fresenius-Stiftung | 27.00 |
Harris Associates LP | 2.99 |
Amundi Asset Management SA (Investment Management) | 2.44 |
Oakmark International Fund | 1.83 |
Government Pension Fund - Global (The) | 1.54 |
Vanguard Total International Stock Index Fund | 1.02 |
Franklin Mutual Ser. Fds. - Global Discovery Fund | 0.85 |
Vanguard Developed Markets Index Fund | 0.63 |
Shareholder percentage totals can add to more than 100% because some holders are included in the free float.
Fresenius Management
Name | Job |
---|---|
Wolfgang Kirsch | Chairman-Supervisory Board |
Michael Sen | Chief Executive Officer |
Pierluigi Antonelli | Chief Executive Officer-Fresenius Kabi |
Sara Hennicken | Chief Financial Officer |
Michael Moser | Head-Legal & Compliance |
Bernd Behlert | Independent Member-Supervisory Board |
Iris Löw-Friedrich | Independent Member-Supervisory Board |
Michael Albrecht | Independent Member-Supervisory Board |
Susanne Zeidler | Independent Member-Supervisory Board |
Christoph Zindel | Member-Supervisory Board |
Frauke Lehmann | Member-Supervisory Board |
Holger Michel | Member-Supervisory Board |
Konrad Kölbl | Member-Supervisory Board |
Oscar Romero de Paco | Member-Supervisory Board |
Alexandra Graulich | Secretary & Head-Corporate Communications |
Markus Georgi | Senior VP-Investor Relations & Sustainability |
Grit Genster | Vice Chairman-Supervisory Board |
Michael Diekmann | Vice Chairman-Supervisory Board |